Benefits of strategic use of statins associated with other hypolipemyants in the dislipidemic patient’s management: summary of evidences
DOI:
https://doi.org/10.37497/ijhmreview.v5i3.182Keywords:
Dyslipidemias. Statins. Management. Fibrates. Antidyslipidemic.Abstract
Dyslipidemia is a multifactorial disease that can be diagnosed by measuring plasma concentrations of lipoproteins important for the transport of both cholesterol and triglycerides, such as triglyceriderich lipoprotein cholesterol and very low density lipoprotein (VLDL ), high-cholesterol, low-density lipoprotein (LDL-C) and, finally, high-density lipoprotein (HDL). The treatment of dyslipidemias can be performed in a multidisciplinary way, however, in most cases, it is necessary to use drugs, which seek to decrease the concentrations of VLDL and LDL-C and increase the concentration of HDL, since it reduces the plasma concentrations of LDL-C decrease the risk of cardiovascular diseases, such as the incidence of major coronary events, revascularizations and stroke. Among the various pharmacological classes available for the pharmacotherapy of dyslipidemias, statins certainly play a prominent role, however, in many cases, statins are presumed to be administered concomitantly with other antidysipidemic drugs, such as ezetimibe (a absorption of cholesterol), fibrates, bile acid sequestrants and nicotinic acid or niacin in order to reduce the high risks of cardiovascular diseases in dyslipidemic patients. Thus, this review aims to discuss the benefits of using statins as monotherapy or in combination with other drugs in the management of dyslipidemic patients with high cardiovascular risk.Downloads
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms: The author(s) authorize the publication of the text in the journal; The author(s) guarantee that the contribution is original and unpublished and is not in the process of being evaluated by any other journal(s); The journal is not responsible for the opinions, ideas, and concepts contained in the texts, as these are the sole responsibility of their respective author(s); The editors reserve the right to make adjustments to the text in order to ensure that it adheres to the standards of the journal. Authors retain the copyrights and grant the journal the right of first publication, with the article simultaneously licensed under the Creative Commons Attribution License which allows the sharing of the article with the acknowledgment of authorship and initial publication in this journal. Authors are authorized to take additional contracts separately, for the non-exclusive distribution of the version of the article published in this journal (e.g. publication in an institutional repository or as a book chapter), with the acknowledgment of authorship and initial publication in this journal.
Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal webpage) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and citation of published work (See The Effect of Free Access at http://opcit.eprints.org/oacitation-biblio.html)